ARCHIVES

In Brief: FDA To Review Preclinical Testing, Phase I Protocols At Open Advisory Group Meeting

This article is from The Cancer Letter archive.

Vol. 01 No. 46 | November 14, 1975

Download PDF Visit The Full Archive

Related Articles

Working Group Considering formal Cap On size of Cancer Center Support Grants

March 22, 1996

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

Group Chairs Respond to Center Directors’ White Paper

April 1, 2011

‘”2015 Goal” Deleted From NCI Web Site.

December 8, 2006

In Brief: Potter Resigns As director Of Lombardi Cancer Center; Search Committee To Look for Successor

July 24, 1987

Shorter, Simpler Consent Form Proposed For Phase I Trials

July 31, 2009